11/2/21 17:49 | 11/1/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 99 | 11.51 | 0 | 9 | 17 | 58 | D | | | | | | | | | | | | | | |
9/7/21 08:03 | 9/2/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 86 | 11.51 | 0 | 8 | 18 | 50 | D | | | | | | | | | | | | | | |
7/29/21 17:05 | 7/28/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 86 | 11.51 | 0 | 8 | 22 | 42 | D | | | | | | | | | | | | | | |
2/26/21 19:50 | 2/24/21 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 105 | 11.51 | 0 | 9 | 36 | 35 | D | | | | | | | | | | | | | | |
9/28/20 18:12 | 9/25/20 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 46 | 11.51 | 0 | 4 | 39 | 14 | D | | | | | | | | | | | | | | |
8/18/20 18:18 | 8/11/20 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.a | 46 | 11.51 | 0 | 4 | 63 | 10 | D | | | | | | | | | | | | | | |
8/12/20 20:32 | 8/11/20 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 46 | 11.51 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
11/5/19 06:08 | 11/4/19 | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | P | 101 | 16.00 | 0 | 6 | New | 6 | D | | | | | | | | | | | | | | |